Mask Is Required for the Activity of the Hippo Pathway Effector Yki/YAP  by Sansores-Garcia, Leticia et al.
Mask Is Required for the ActCurrent Biology 23, 229–235, February 4, 2013 ª2013 Elsevier Ltd All rights reserved http://dx.doi.org/10.1016/j.cub.2012.12.033Report
ivity
of the Hippo Pathway Effector Yki/YAPLeticia Sansores-Garcia,1,3,4,6 Mardelle Atkins,1,3,4,6
Ivan M. Moya,3,4 Maria Shahmoradgoli,2 Chunyao Tao,1
Gordon B. Mills,2,5 and Georg Halder1,3,4,5,*
1Department of Biochemistry and Molecular Biology
2Department of Systems Biology
The University of Texas MD Anderson Cancer Center,
Houston, TX 77030, USA
3VIB Center for the Biology of Disease
4KU Leuven Center for Human Genetics
University of Leuven, 3000 Leuven, Belgium
5Graduate School of Biomedical Sciences, The University
of Texas, Houston, TX 77030, USA
Summary
The Drosophila Yorkie (Yki) protein and its mammalian
homolog Yes-associated protein (YAP) are potent growth
promoters, and YAP overexpression is associated with
multiple types of cancer [1, 2]. Yki and YAP are transcrip-
tional coactivators and function as downstream effectors
of the Hippo tumor suppressor pathway [1–4]. The regula-
tion of Yki and YAP by the Hippo signaling pathway has
been extensively investigated; however, how they regulate
gene expression is poorly understood. To identify additional
regulators of Yki activity, we performed a genome-wide RNAi
screen in Drosophila S2 cells. In this screen, we identified
the conserved protein Mask (Multiple ankyrin repeats single
KH domain) as a novel promoter of Yki activity in vitro and
validated this function in vivo in Drosophila. We found that
Mask is required downstream of the Hippo pathway for Yki
to induce target-gene expression and that Mask forms
complexes with Yki. The human Mask homolog MASK1
complexes with YAP and is required for the full activity of
YAP. Additionally, elevatedMASK1 expression is associated
with worsened outcomes for breast cancer patients. We
conclude that Mask is a novel cofactor for Yki/YAP required
for optimal Yki/YAP activity during development and
oncogenesis.
Results and Discussion
Mask Is a Positive Regulator of Yki Activity In Vitro
To identify new components of the Hippo pathway and poten-
tial regulators of Yorkie (Yki) activity, we performed a genome-
wide RNAi screen in S2 cells, using a Yki-dependent luciferase
assay [5, 6]. In this assay, a fusion protein between Yki and the
GAL4 DNA-binding domain (Yki-GDBD) drives expression of
a UAS-luciferase construct. Coexpression of Expanded (Ex)
was used to activate the Hippo pathway and diminish baseline
Yki activity [6]. In a secondary assay, we eliminated false posi-
tives that have general effects on transcription by testing for
effects on a fusion protein between Scute (Sc) and the GAL4
DNA-binding domain (GDBD). Sc-GDBD is not regulated by6These authors contributed equally to this work
*Correspondence: georg.halder@med.kuleuven.beHippo signaling but induces luciferase expression levels
comparable to the Yki-GDBD construct [6]. In this screen, we
identified the known Hippo pathway components Hpo, Ex,
Wts, Kibra, Sav, and Mats, as well as actin regulators [6], as
negative regulators of Yki activity, which validated the
screening strategy and supported its utility for identifying
novel components of the pathway (Figure 1A). In addition to
these negative Yki regulators, we identified Multiple ankyrin
repeats single KH domain (Mask) as a protein that promotes
Yki activity (Figure 1A). Knockdown of mask resulted in
a 50% reduction of Yki-GDBD-induced luciferase expression,
whereas it did not affect Sc-GDBD-induced reporter expres-
sion (Figure 1B). These results indicate that the reduction in
Yki activity caused by mask knockdown is specific and is not
the consequence of general effects on transcription. We
focused our further studies on Mask because knockdown of
mask had some of the strongest effects on Yki-GDBD activity
observed in the screen (apart from knockdowns that resulted
in cell death) and because Mask also had robust and specific
effects on Yki activity in vivo.
Mask Is Required for Normal Tissue Growth and Yki
Target-Gene Expression in Drosophila
Mask is a large protein of 4,001 amino acids that contains two
clusters of ankyrin repeats (Ank1 and Ank2) and a single KH
domain in its C terminus (Figure 1C) [7]. Ankyrin repeats are
known to mediate protein-protein interactions, and KH
domains can mediate protein-nucleic acid interactions [8, 9].
Previous studies identified mutations in mask as modifiers of
epidermal growth factor (EGF) signaling and also identified a
role for Mask in photoreceptor differentiation, cell survival,
and proliferation in Drosophila [7], although the molecular
mechanism of Mask action was not known. Mask is conserved
in humans,where there are twohomologs,MASK1 (also known
as ANKHD1) and MASK2 (also known as GTAR or ANKRD17)
(Figure 1C) [7, 10]. MASK1 is overexpressed in acute leukemia
patient cells andcell lines [11] and regulates cell-cycle progres-
sion and proliferation in multiple myeloma [12]. MASK2 is
essential for vascular integrity during embryogenesis [13].
To investigate a potential role for Mask in Hippo signaling
in vivo, we first tested whether there is a general requirement
for mask in tissue growth. We found that larvae with mosaic
eye discs, in which most cells were homozygous mutant for
the null allele mask5.8 [7], produced flies with small eyes that
lacked mutant cells and had only a few heterozygous cells
(Figures 1D and 1E). Eye discs mosaic for the hypomorphic
mask6.3 allele [7] also produced small eyes but contained
homozygous cells, although their amounts were still far below
control eyes (Figures 1D and 1F). In imaginal discs, mask null
clones grew poorly in all areas of developing eye and wing
discs and were eventually eliminated during late stages of
development, and hypomorphic clones grew at reduced
rates (see Figures S1A–S1C available online) [7]. Broad knock-
down of mask during eye development by ey-GAL4-
driven expression of genome-encoded double-stranded
RNAs (ey-GAL4>UAS-maskRNAi) resulted in adult flies that
had severely reduced eyes (Figures S1E–S1G). Similarly,
knockdown ofmask expression in the developing wing pouch,
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Figure 1. Mask Is A Positive Regulator of Yki Activity
(A) Luciferase (luc) activity assay to measure the activity of a Yki-GAL4 DNA-binding-domain (Yki-GDBD) fusion protein on a UAS-luc reporter plasmid
normalized with Renilla Luc expressed from a constitutive promoter. S2 cells were transfected with UAS-luc-, Yki-GDBD-, and HA-Ex-expressing plasmids
in the presence of double-stranded RNAs as indicated.
(B) Similar to (A) but using a Scute (Sc)-GDBD construct instead of Yki-GDBD.
(C) Schematic of Drosophila and human Mask proteins, indicating conserved domains.
(D–F) Adult flies with white control clones (D), mask5.8 null clones (E), and mask6.3 hypomorphic clones (F).
(G) Confocal image of a third-instar antennal imaginal disc showingmask6.3 hypomorphic clones marked by the lack of GFP and stained for ex-lacZ expres-
sion (red, gray in G0).
(H–J) Confocal images of third-instar wing imaginal discs expressing GFP alone or together withmaskRNAi or ykiRNAi in the posterior compartment driven by
hh-GAL4 and stained for ex-lacZ (red or gray in the 0 panels).
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230using the nub-GAL4 driver, resulted in smaller wings with
some wing margin defects (Figures S1H–S1K). Notably, four
different nonoverlapping mask-RNAi constructs showed
similar effects, although with varying strengths (Figure S1),
and mask mRNA levels were reduced even by a moderate
RNAi line, asmeasured by qRT-PCR (Figure S1M). On the other
hand, overexpression of Mask using nub-GAL4 driving differ-
ent EY insertions in mask did not affect wing size (data not
shown). These data indicate that Mask is generally required
for normal tissue growth, similar to the requirement for Yki [5].
Based on our in vitro data and the requirement for Mask in
tissue growth, we hypothesized that Mask acts in the Hippo
pathway. To test this hypothesis, we examined the expression
of Yki target genes in cells with reduced mask expression.Clones of cells mutant for the null allelemask5.8were generally
composed of only very few cells and thus difficult to analyze
(Figure S1B). However, clones mutant for the hypomorphic
mask6.3 allele were larger and showed reduced expression of
the expanded-lacZ (ex-Z) reporter, a commonly used and
sensitive readout for Yki activity (Figure 1G) [14]. Likewise,
when mask expression was knocked down in the posterior
compartment of developing wing discs by RNAi, ex-lacZ was
strongly reduced when compared to control discs and to its
expression in the anterior compartment (Figures 1H and 1I).
In addition, compartment size was reduced (Figures 1H and
1I). This result is strikingly similar to the reduced expression
of ex-lacZ and small compartment size observed when yki
expression was knocked down in the posterior compartment
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231using RNAi (Figure 1J) [15]. Knockdown of mask also caused
reduction of other Yki target genes such as diap1-lacZ (Figures
S2A and S2B). To support the specificity of the RNAi-induced
phenotypes, we repeated these experiments using different
UAS-RNAi lines targeting nonoverlapping regions of mask,
and each showed similar phenotypes (Figures S2C and S2D).
However, levels of Cubitus interruptus (Ci) (Figures S2E and
S2F) and a phosphorylated form of Mothers against Dpp
(pMad) (Figures S2G and S2H), used as Hedgehog and Dpp
pathway readouts respectively, were not notably affected,
indicating that the effects of Mask knockdown are specific.
Thus, Mask is required for the activation of Yki target genes.
Mask Forms Complexes with Yki and Is Required for Yki
Activity In Vivo
If Mask is necessary for normal Yki activity in vivo, then mask
knockdown should modify Hippo pathway phenotypes in
a manner similar to yki knockdown. To determine whether
that is the case and to place the action of Mask within the
Hippo pathway, we decreased Hippo pathway activity using
RNAi against fat, ex, and hpo alone or in combination with
knockdown of mask or yki. Knockdown of fat, ex, or hpo in
developing wing discs by the nub-Gal4 driver causes hyperac-
tivation of Yki and resulted in overgrown adult wings (Figures
2A and 2B; data not shown) [16, 17]. Conversely, knockdown
of yki or mask resulted in wings that were much smaller than
normal (Figures 2C and 2G) [15]. Simultaneous knockdown
of hpo, ex, or fat together with yki produced the yki knockdown
phenotype of small wings, showing that Yki activity is required
for the overgrowth caused by Hippo pathway inactivation, as
expected (Figure 2H). Similarly, when mask was knocked
down together with fat, ex, or hpo, wing overgrowth was sup-
pressed and the adult wings were small (Figure 2D; data not
shown). These results indicate that Mask functions within the
Hippo pathway downstream of Fat, Ex, and Hpo.
We then tested whether Yki activity itself was dependent
upon Mask. To investigate this, we first overexpressed Yki
with and without knockdown of mask. Overexpression of
wild-type Yki is sufficient to induce wing overgrowth (Fig-
ure 2E) [5], but, in combination with knockdown of mask, the
adult wings exhibited the maskRNAi phenotype (Figure 2F),
namely small wings with distal scalloping (Figure 2C). Thus,
overexpressed Yki requires Mask to cause overgrowth.
However, wild-type Yki can still be regulated byWts phosphor-
ylation, and this experiment thus does not discriminate
between direct effects on Yki and indirect effects through
modulating Wts. We therefore repeated this experiment with
mutant versions of Yki, namely Yki1SA and Yki3SA, in which
the main or all three Wts phosphorylation sites were mutated
to alanine [18]. Overexpression of Yki1SA or Yki3SA by nub-
GAL4 caused severe overgrowth phenotypes in discs (Figures
2I–2L), which were not able to produce adult wings. Coexpres-
sion ofmask-RNAi partially rescued these overgrowth pheno-
types, indicating that even nonphosphorylatable Yki requires
Mask for its growth-inducing activity (Figures 2M–2P, quanti-
fied in Figure 2Q). To further quantify the effects of Mask on
the activity of Yki independent of Wts phosphorylation, we
used the Yki-GDBD luc assay in S2 cells. We found that
Mask was again required for the full activity of Yki with
wtsRNAi and of unphosphorylatable Yki3SA (Figure 2R).
However, mask knockdown did not completely inactivate
wild-type or mutant Yki, even though mask mRNA levels
were nearly undetectable in mask RNAi cells (Figure 2S).
Therefore, Mask is not absolutely required for Yki activity.This conclusion was further confirmed in S2 cells, where
knockdown of mask reduced the activity of a reporter
construct containing binding sites for Scalloped (Sd), a tran-
scription factor that interacts with Yki, by about 50% (Figures
2T and 2U). This was true when the reporter was driven by
endogenous levels of Yki and Sd (Figure 2T) or when Yki was
overexpressed (Figure 2U). We next analyzed the clonal
growth and levels of ex-lacZ expression in wts single-mutant
and wts, mask double-mutant clones. wts null mutant clones
grew large and consistently had high levels of ex-lacZ expres-
sion (Figure 2V). In contrast, wts, mask double-null mutant
clones were generally smaller, and about half of these clones
had no or weak upregulation of ex-lacZ expression (Figure 2W,
arrowhead), although the other half had elevated levels
(Figure 2W, asterisk). These in vivo data thus show that
Mask is required for the full wts mutant phenotype but that
loss of Wts can still enhance the activity of Yki, even in the
absence of Mask. Altogether, the in vivo and in vitro experi-
ments show that Mask is required for full activity of Yki and
that at least part of this function is independent (in parallel or
downstream) of the activity of Wts.
The above data indicate that the activities of Mask and Yki
may be closely linked. To determine whether Mask can phys-
ically interact with Yki, we coimmunoprecipitated V5-tagged
Yki with HA-tagged Mask constructs. We found that the
Ank2 and KH domains, as well as a construct that contained
the Ank2-KH domains together, formed complexes with Yki,
whereas Ank1 complexed weakly (Figure 3A). We also tested
for interaction with Wts but found that none of the Mask
domains bound to Wts (Figure 3A). This experiment also
demonstrates the specificity of the interaction between Mask
and Yki. Together with our in vivo and S2 cell data, we
conclude that Mask represents a novel component of the
Hippo pathway that positively regulates Yki activity, likely
through a direct interaction with Yki.
We then assayed whether Mask and Yki influence each
other’s subcellular localization. Mask and Yki are localized
mainly in the cytoplasm in imaginal disc cells and in S2 cells
[5, 7], and Yki translocates to the nucleus when the Hippo
pathway is inactivated [5]. However, we did not observe signif-
icant effects on Mask localization in wts mutant clones
(Figures S3A and S3B). We then tested whether, in S2 cells,
nuclear translocation of Yki is sufficient to recruit Mask into
the nucleus. For this experiment, we analyzed the localization
of tagged Yki and tagged Ank2-KH Mask proteins. We
found that coexpression of Sd efficiently recruited Yki into
the nucleus, but not Mask (Figure 3F, quantified in Figures
3G and 3H). Thus, Mask and Yki do not form obligatory
complexes, and the regulation of Mask localization may be
independent of the Hippo pathway. Conversely, knockdown
of mask caused a slight increase in nuclear localization of Yki
in S2 cells, similar to the effect of wts knockdown (Figure 3I).
Knockdown ofmask in imaginal discs did not noticeably affect
the localization pattern of Yki, but it resulted in an increase of
Yki protein levels (Figures S3C and S3D). However, even
though mask RNAi cells had elevated levels of Yki protein,
they had less Yki activity, further supporting the idea that
Mask is required for full activity of Yki.
MASK1 Is Required for Full YAP Activity, and MASK1
Expression Levels Correlate with Breast Cancer Patient
Outcomes
In mammals, the Hippo pathway controls organ size and cell
proliferation by regulating the activity of the Yki homologs
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Figure 2. Mask Is Required for Full Yki Activity
Independent of Wts Phosphorylation
(A–H) Pictures of wings from flies expressing the
indicated constructs driven by the wing-specific
nubbin-GAL4 driver. ‘‘maskRNAi’’ refers to the
VDRC v33396 maskRNAi line.
(I–P) Confocal images of third-instar wing discs
with nubbin-GAL4 driving GFP plus the indicated
constructs. GFP is in green and nuclei are stained
with DAPI displayed in blue.
(Q) Quantification of the GFP-expressing area of
imaginal discs with the genotypes shown in (I)–(P)
(median area of GFP pixels 6 SEM, n = 5).
(R) Luciferase assay on S2 cells transfected with
plasmids expressing UAS-luc and wild-type Yki-
GDBDor Yki3SA-GDBD fusion proteins in the pres-
ence of the indicated dsRNAs.
(S) Quantification of mask mRNA levels by qRT-
PCR from S2 cells transfected with dsRNA target-
ing GFP or mask.
(T) Luciferase assay on S2 cells transfected with
the Yki/Sd-responsive 3xSd-luc reporter, which
has multimerized Sd-binding sites, in the presence
of the indicated dsRNAs and normalized to
b-galactosidase activity expressed fromaconstitu-
tive promoter.
(U) Luciferase assay on S2 cells transfected with
the 3xSd-luc reporter and Yki-expressing plasmids
in the presence of the indicated dsRNAs.
(V) wtsx1 null mutant clones in a wing disc marked
by lack of GFP and stained for ex-lacZ expression
(red, gray in V0).
(W) mask10.22 wtsx1 double-mutant clones in a
wing disc stained for ex-lacZ expression (red,
gray in W0). The arrowhead indicates a clone with
low levels of ex-lacZ expression, and the asterisk
indicates a clone with upregulated ex-lacZ
expression.
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232YAP and TAZ, which can complex with the Sd-homologous
TEAD transcription factors to activate target-gene expression
[1, 3–5]. We found that immunoprecipitation of endogenousMASK1 copurified YAP, indicating that
MASK1 and YAP form complexes (Fig-
ure 4A). In addition, we found that immu-
noprecipitation of MASK1 also copurified
endogenous TEAD3 (Figure 4A). Knock-
down of MASK1 significantly reduced
the amount of coimmunoprecipitated
YAP and TEAD3, whereas the total
amount of YAP in the cell lysates was
not affected, and TEAD3 was slightly
lower (Figure 4A). We next wanted to
determine the cellular localization of these
proteins. MASK1 mainly localized to
the cytoplasm, and YAP was evenly
distributed in nuclei and cytoplasm in
our assay conditions (Figures 4B and
4C). We then used the proximity ligation
assay (PLA) to visualize the localization
of the heteromers of MASK1 with YAP
or TAZ. Such heteromers were readily
detected in the cytoplasm but also
observed in the nuclei of HEK293T cells
treated with nontargeting siRNAs (Figures
4D and 4F; Figure S4). Upon MASK1
knockdown, the number of complexeswas significantly reduced (Figures 4E and 4F; Figure S4).
Together, these data indicate that endogenous MASK1 and
YAP form complexes.
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Figure 3. Mask Complexes with Yki but Localizes Independently of Yki
(A) Immunoprecipitation of lysates from S2 cells transfected with Yki-V5 and different HA-Mask or V5-Wts and HA-Yki constructs. Top shows an anti-V5
western blot from an anti-HA immunoprecipitation. Panels below show anti-V5 and anti-HA western blots to detect expression of the input proteins and
an anti-histoneH3westernblot as a loadingcontrol. Lane 1: V5-Wts coexpressedwithHA-taggedAnk1, Ank2, andKHdomains ofMask. Lane 2: Yki-V5 alone.
Lanes 3–6: Yki-V5 coexpressedwith the Ank1, Ank2, KH, or Ank2-KH constructs, respectively. Lane 7: Yki-HA coexpressedwith V5-Wts as apositive control.
(B–F) Confocal images of S2 cells transfected with the constructs indicated on the left and stained for the antigens indicated on the top. Nuclei were labeled
with DAPI shown in blue.
(G) Quantification of the localization of Yki-V5 in (B)–(F).
(H) Quantification of the localization of Mask in (C), (D), and (F).
(I) Quantification of endogenous Yki localization in S2 cells transfected with dsRNAs targeting GFP, wts, or mask.
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233To examine whether MASK1 is required for the transcrip-
tional activity of YAP/TEAD complexes, we assayed the ability
of MASK1 to modulate the activity of a commonly used TEAD
luciferase reporter [19]. We transfected HEK293T cells with
si-MASK1, which resulted in a significant reduction of
MASK1 expression (Figure 4G) and significantly reduced
TEAD-dependent luciferase reporter activity when compared
with a nontargeting siRNA control (p < 0.005) (Figure 4H). We
also assayed for YAP/TEAD target-gene expression by qRT-
PCR in HEK293T cells transfected with si-MASK1 or nontar-
geting siRNA. We found that the expression of the YAP
target genes CTGF, ANKRD1, FN1, and CYR61 were signifi-
cantly reduced, whereas nontarget genes, such as KRAS,
NRAS, and MYC, as well as YAP and TAZ themselves, were
not affected (Figure 4I). Together, these data indicate that
MASK1 is required for full activity of YAP/TEAD.
Deregulation of the Hippo pathway is frequently detected in
human cancers, and increased YAP activity correlates withpoor prognosis and patient survival [1, 2]. Additionally,
MASK1 is overexpressed in acute leukemias [11] and regulates
cell-cycle progression and proliferation in multiple myeloma
cells [12], suggesting that it may have oncogenic activity. To
examine whether there is a relationship between clinical prog-
nosis and expression of MASK1 in human cancers, we
analyzed gene expression profiles of different breast cancer
data sets, using probes that identify the first ankyrin domain
of MASK1 mRNA. We found that low expression of MASK1 is
associated with significantly better relapse-free survival in
two independent data sets (p < 0.007, p < 0.014): University
of North Carolina (data sets from [20–22] hosted by the UNC
Microarray Database at https://genome.unc.edu) (Figure 4J)
and Pawitan et al. [23] (Figure 4K). These findings suggest
that MASK1 levels are an important factor in the aggressive-
ness of cancer progression and patient outcomes.
In summary, we identifiedMask as a novel component of the
Hippo pathway. We found that Mask and its mammalian
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Figure 4. MASK1 Interacts with YAP and TEAD3
and Regulates YAP Activity, and Its Expression
Levels Correlate with Breast Cancer Patient
Outcomes
(A) Lysates of HEK293T cells treated with nontar-
geting or MASK1 siRNAs were immunoprecipi-
tated for endogenous MASK1 and immuno-
blotted for YAP1 or TEAD3.
(B and C) Endogenous MASK1 (green, gray in B0
and C0) and YAP (red, gray in B00 and C00) localiza-
tion in HEK293T cells treated with nontargeting
(B) or MASK1 siRNAs (C).
(D and E) MASK1/YAP heteromers (red) detected
by in situ proximity ligation assay (PLA), using
MASK1 and YAP antibodies in cells treated with
nontargeting (D) or MASK1 siRNA (E).
(F) Quantification of the PLA signals in (D) and (E).
(G)Western blot demonstrating the level of siRNA
knockdown of MASK1 protein in HEK293T cells.
(H) Relative luciferase activity of a luciferase
reporter plasmid with TEAD-binding sites and
the control vector in HEK293T cells cotransfected
with MASK1 siRNA and a nontargeting siRNA.
The error bars represent mean 6 SE (n = 6)
(*p < 0.005).
(I) qRT-PCR analysis of mRNA expression of YAP
target genes in HEK293T cells treated with non-
targeting or MASK1 siRNAs.
(J and K) Kaplan-Meier graphs showing a signifi-
cant association ofMASK1 expression levels with
relapse-free survival (RFS) in independent data
sets of breast cancer patients (p < 0.007 and
p < 0.014, log rank test). Scale bars represent
20 mm.
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234homolog MASK1 form complexes with the Hippo pathway
effector Yki/YAP and are required for full activity of Yki/YAP.
We also found that MASK1 expression levels correlate
with breast cancer patient outcomes. In an accompanying
paper in this issue of Current Biology, Sidor et al. [24]
similarly report an interaction between Mask and Yki/YAP.
The mechanism by which Mask/MASK1 potentiates Yki/YAP
activity is currently not known, but our data suggest a
model in which Mask/MASK1 acts in the nucleus to promote
Yki/YAP’s transcriptional coactivator function, although
Mask/MASK1 may also function in the cytoplasm to pro-
mote Yki/YAP activity. In any case, our data indicate that
Mask/MASK1 acts in parallel to the Wts-mediated phos-
phorylation and regulated localization, and Mask/MASK1
may thus identify a novel regulatory branch of the Hippo
pathway.
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